Physician profile
Elie Fahed
NPI 1356492482
$391,299.67
in general payments reported to CMS, 2019-2025
100 companies · $67K in 2025
The $67K reported for 2025 was more than what 98% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $22K · 2021: $43K · 2022: $102K · 2023: $90K · 2024: $48K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Consulting Fee: $79K · Travel and Lodging: $27K · Food and Beverage: $15K · Education: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $82,278.50 |
| Consulting Fee | $78,866.00 |
| Travel and Lodging | $26,693.17 |
| Food and Beverage | $15,290.39 |
| Education | $818.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $156,112.25 | 2019-2025 | Opdivo, Reblozyl, Augtyro |
| Daiichi Sankyo INC. | $44,740.26 | 2020-2025 | Enhertu, Vanflyta, Datroway |
| Astellas Pharma US INC | $28,859.95 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Celgene Corporation | $22,629.86 | 2019-2024 | Reblozyl, Pomalyst, Opdualag |
| Astrazeneca Pharmaceuticals Lp | $20,404.72 | 2019-2025 | Imfinzi, Lynparza, Truqap |
| Incyte Corporation | $18,313.99 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Glaxosmithkline, LLC. | $16,625.78 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Seagen INC. | $11,049.48 | 2019-2025 | Padcev, Adcetris, Tukysa |
| Adc Therapeutics America, INC. | $9,121.97 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $6,258.63 | 2019-2025 | |
| Pfizer INC. | $5,750.97 | 2019-2025 | |
| Stemline Therapeutics INC. | $5,084.97 | 2023-2025 | Orserdu |
| Beigene USA, INC. | $4,191.29 | 2022-2025 | Brukinsa, Tevimbra |
| Karyopharm Therapeutics INC. | $4,080.13 | 2020-2024 | Xpovio |
| Avyxa Pharma, LLC | $3,805.37 | 2024-2025 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,790.88 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $3,495.18 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Astellas Pharma Global Development | $2,785.37 | 2022-2024 | Xtandi, Padcev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,691.94 | 2019-2022 | |
| Varian Medical Systems, INC. | $1,575.00 | 2019-2021 | |
| G1 Therapeutics, INC. | $1,522.45 | 2022 | |
| Janssen Biotech, INC. | $1,496.87 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Siemens Medical Solutions USA, INC. | $1,400.00 | 2025 | Aria Radiation Therapy Management Software |
| Takeda Pharmaceuticals U.S.A., INC. | $1,201.56 | 2019-2024 | Entyvio, Ninlaro |
| US Oncology Corporate, INC. | $1,163.49 | 2022 | |
| Novartis Pharmaceuticals Corporation | $981.48 | 2019-2025 | |
| Blueprint Medicines Corporation | $962.94 | 2021-2024 | Ayvakit |
| Genentech USA, INC. | $865.13 | 2019-2025 | Tecentriq, Venclexta, Tecentriq Hybreza |
| Amgen INC. | $841.78 | 2019-2025 | Imdelltra (Amg757), Nplate, Xgeva |
| Macrogenics, INC. | $800.00 | 2021 | |
| Merck Sharp & Dohme LLC | $729.32 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Exelixis INC. | $694.81 | 2023-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $658.49 | 2021-2025 | Ultomiris |
| Myriad Genetic Laboratories, INC. | $517.88 | 2020-2024 | Myrisk |
| Abbvie INC. | $498.07 | 2019-2025 | |
| Beigene, Ltd. | $450.00 | 2020 | |
| Emd Serono, INC. | $431.20 | 2019-2024 | Bavencio |
| Pharmacyclics LLC, An Abbvie Company | $377.50 | 2019-2023 | Imbruvica, Epkinly |
| Sumitomo Pharma America, INC. | $353.30 | 2023-2025 | Orgovyx |
| Kite Pharma, INC. | $324.89 | 2019-2025 | Yescarta |
| Regeneron Healthcare Solutions, INC. | $283.99 | 2023-2025 | Libtayo |
| Sanofi-Aventis U.S. LLC | $235.98 | 2019-2023 | |
| Myovant Sciences INC. | $230.11 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $221.11 | 2021-2025 | Fotivda |
| Novocure Gmbh | $200.00 | 2022 | |
| Eisai INC. | $167.22 | 2020-2025 | |
| Lilly USA, LLC | $160.68 | 2019-2025 | Jaypirca, Verzenio |
| Jazz Pharmaceuticals INC. | $155.43 | 2023-2025 | |
| Medtronic Vascular, INC. | $152.29 | 2019 | |
| Athenex Pharmaceutical Division, LLC | $150.00 | 2020 | |
| Gilead Sciences, INC. | $148.42 | 2019-2024 | |
| Coherus Oncology, INC. | $147.22 | 2021-2024 | |
| Pharmaessentia USA Corporation | $125.00 | 2025 | Besremi |
| Tempus Ai, INC | $123.36 | 2025 | Xt Cdx |
| Sobi, INC | $115.90 | 2022-2025 | |
| Heron Therapeutics, INC. | $108.45 | 2019-2024 | Sustol |
| Ipsen Biopharmaceuticals, INC | $101.00 | 2021-2025 | Onivyde |
| Cardinal Health 110 LLC | $100.00 | 2020 | |
| Comsort, INC | $100.00 | 2019 | |
| Adaptive Biotechnologies Corporation | $87.82 | 2023-2025 | Clonoseq |
| Dova Pharmaceuticals | $87.35 | 2019-2021 | |
| Array Biopharma INC | $81.30 | 2019-2025 | Mektovi, Braftovi, Tukysa |
| Mirati Therapeutics, INC. | $80.25 | 2023-2024 | Krazati |
| Puma Biotechnology, INC. | $77.95 | 2019-2025 | |
| Legend Biotech USA INC. | $73.39 | 2024-2025 | Carvykti |
| Accord Healthcare, INC. | $70.27 | 2024-2025 | |
| Cti Biopharma Corp. | $65.54 | 2022-2023 | Vonjo |
| Acrotech Biopharma INC. | $63.92 | 2021-2022 | |
| Kyowa Kirin, INC. | $62.60 | 2019-2022 | |
| Clovis Oncology, INC. | $61.08 | 2019-2022 | |
| Rigel Pharmaceuticals, INC. | $60.36 | 2019-2023 | Tavalisse, Rezlidhia |
| Fresenius Kabi USA, LLC | $58.93 | 2023-2024 | Stimufend |
| Taiho Oncology, INC. | $58.80 | 2021-2024 | |
| Foundation Medicine, INC. | $51.19 | 2020-2023 | |
| Fennec Pharmaceuticals, INC. | $46.47 | 2024 | Pedmark |
| Servier Pharmaceuticals LLC | $44.60 | 2021-2022 | |
| Spectrum Pharmaceuticals INC. | $40.28 | 2023 | Rolvedon |
| Agios Pharmaceuticals, INC. | $39.24 | 2025 | Pyrukynd |
| Tolmar Pharmaceuticals, INC. | $36.13 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $33.25 | 2025 | Monoferric |
| Deciphera Pharmaceuticals INC. | $31.11 | 2023-2024 | Qinlock |
| Beone Medicines USA, INC. | $29.10 | 2025 | Tevimbra, Brukinsa |
| Cycle Pharmaceuticals INC | $25.76 | 2025 | Phyrago |
| Janssen Pharmaceuticals, INC | $25.72 | 2024 | |
| Celltrion USA INC. | $23.04 | 2025 | Vegzelma |
| Caris Mpi, INC. | $22.93 | 2025 | Mi Cancer Seek |
| Immunogen, INC. | $20.12 | 2023 | Elahere |
| Dendreon Pharmaceuticals LLC | $19.89 | 2020 | |
| Tersera Therapeutics LLC | $19.01 | 2023 | Zoladex |
| Genmab U.S., INC. | $16.84 | 2022 | |
| Genentech, INC. | $15.36 | 2021 | |
| X4 Pharmaceuticals, INC. | $14.42 | 2025 | Xolremdi |
| Helsinn Therapeutics (U.S.), INC. | $13.23 | 2019 | |
| Morphosys, US INC. | $13.03 | 2021 | |
| Roche Diagnostics Corporation | $12.84 | 2020 | |
| Verastem, INC. | $12.83 | 2019 | |
| Eusa Pharma (US) LLC | $12.28 | 2020 | |
| Aurobindo Pharma USA, INC. | $12.08 | 2020 | |
| Horizon Therapeutics Plc | $11.27 | 2019 | |
| Iovance Biotherapeutics, INC. | $2.78 | 2025 | Amtagvi |
Drugs and devices associated with these payments
Opdivo $47KPadcev $35KEnhertu $24KReblozyl $8,278Augtyro $6,857Nubeqa $6,227Imfinzi $5,579Pomalyst $5,363Orserdu $5,085Brukinsa $2,525Xtandi $1,521Ibrance $1,451Aria Radiation Therapy Management Software $1,400Jakafi $980Lynparza $705Cabometyx $695Vanflyta $650Orgovyx $601Carvykti $542Truqap $525Calquence $525Rybrevant $503Myrisk $484Keytruda $415Imbruvica $321Ojjaara $286Libtayo $284Ultomiris $275Erleada $268Epkinly $258Bavencio $237Kisqali $211Xofigo $206Talzenna $204Darzalex $204Monjuvi $190Krazati $187Tecvayli $185Venclexta $178Opdualag $170Yescarta $162Adcetris $158Fotivda $155Elrexfio $151Akeega $148Jevtana $145Sarclisa $142Imdelltra (Amg757) $140Tecentriq $140Pemazyre $134Talvey $126Ziihera $125Tagrisso $125Besremi $125Xt Cdx $123Tecentriq Hybreza $103Comirnaty $96.86Tukysa $90.41Clonoseq $87.82Vonjo $79.67Xpovio $78.64Lutathera $78.12Lenvima $77.37Vectibix $76.92Welireg $72.63Camcevi $70.27Bosulif $65.07Besponsa $65.07Datroway $63.74Mektovi $61.55Braftovi $61.55Scemblix $59.57Stimufend $58.93Zejula $58.93Jemperli $58.93Onivyde $53.36Fabhalta $50.03Lupron Depot $46.59Pedmark $46.47Nplate $45.67Xgeva $45.67Vyloy $44.30Keytruda Qlex $43.39Jaypirca $42.23Verzenio $42.23Piqray $41.91Rolvedon $40.28Doptelet $39.38Pyrukynd $39.24Nerlynx $38.65Injectafer $34.74Monoferric $33.25Promacta $32.57Paxlovid $31.86Polivy $31.84Entyvio $31.75Qinlock $31.11Tevimbra $31.05Zepzelca $30.43Ayvakit $28.88
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elie Fahed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.